AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LOPERAMIDE HCL

12 registrations across 5 African markets— 9 active

Markets with LOPERAMIDE HCL

Recent registrations

Brand / ProductMarketHolderStatusExpires
Klopera tablets
Capsules
🇿🇲ZambiaKamal InternationalactiveDec 2030
RYDOL CAPSULES🇬🇭GhanaactiveDec 2028
RYDOL CAPSULES🇬🇭GhanaactiveDec 2028
DAPPRESS CAPSULES🇬🇭GhanaactiveApr 2027
DAPPRESS CAPSULES🇬🇭GhanaactiveApr 2027
COLODIUM CAPSULES🇬🇭GhanaexpiredAug 2026
COLODIUM CAPSULES🇬🇭GhanaexpiredAug 2026
LOPERAMIDE-HCL 2MG CAPSULE
CAPSULE
🇲🇼MalawiexpiredMar 2025
IMODIUM 2 GELU BTE (20) JANSSEN-CILAG
gélule, boîte de 1x20
🇲🇬MadagascarJANSSEN-CILAGactive
LOPERAMIDE HCL
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaREGAL PHARMACEUICAL S LTDactive
LOPERAMIDE HCL
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaREGAL PHARMACEUICAL S LTDactive
IMODIUM 2 GELU BTE (20) JANSSEN-CILAG
gélule, boîte de 1x20
🇲🇬MadagascarJANSSEN-CILAGactive

LOPERAMIDE HCL in Africa — Regulatory Overview

LOPERAMIDE HCL is registered across 5 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Madagascar, Uganda, Malawi and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 9 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.